Can nicotine pouches take the baton from cigarettes and become the next super growth curve for the international tobacco majors? When Reuters put that question formally on the table, it meant the unremarkable little white pouch had crossed out of its niche and onto the core strategic agenda of every global tobacco group.
Why now, and why this product rather than the vapes and heated tobacco the majors poured money into for a decade? The answer is in the form factor. A nicotine pouch generally contains no tobacco leaf, needs no combustion, produces neither smoke nor vapour, and has no battery, no charging, no coil and no heater. It compresses an entire device ecosystem into a portable consumer good that works in far more situations.
Why Now? The Majors Have Run Out of Patience
Conventional cigarettes remain under sustained pressure from policy, health awareness and falling smoking rates. Meanwhile the two great hopes of the last decade — vaping and heated tobacco — both hit structural ceilings: a high device barrier, fiddly hardware servicing, and venue-level restrictions. Against that backdrop, a product that dispenses with electronics entirely shows unusual commercial efficiency.
More to the point, the category now has quantifiable growth expectations attached to it. BAT projects global nicotine pouch industry revenue rising from about £4 billion in 2025 to about £11 billion by 2030, with user numbers potentially reaching 47 million. Euromonitor forecasts a roughly 20.5% compound annual growth rate for smokeless oral nicotine volumes globally between 2025 and 2030.
These are company and analyst projections, not achieved results. Sources: BAT public materials, Euromonitor, via Reuters.
Forecasts are not outcomes. But they are enough to explain why no mainstream tobacco group is willing to sit this one out.
Eight Times the Unit Margin
The clearest move was PMI’s roughly $16 billion acquisition of Swedish Match in 2022, bringing ZYN in-house. What excited capital markets was not how small the packaging is. It was how striking the unit economics are.
On PMI’s disclosure, calculated on 2024 figures, its US nicotine pouch business generated gross profit per thousand units roughly eight times that of its international cigarette business. Its IQOS heated tobacco business ran at roughly 2.4 times.
The “8×” figure is PMI’s own company basis and does not represent an industry average.
There is nothing mysterious behind the margin. No device means lower hardware cost and no after-sales burden. Small format means more efficient warehousing, logistics and shelf presence. And flavour, strength, pouch format, moisture, release rate and pack design all leave brands substantial room to differentiate. For an adult consumer category with stable repeat purchase, that combination — light format, high frequency, many variants — is the business model everyone wants.
Cultural Barriers Are Real, but Habits Are Not Fixed
Pouches run fast in the United States and the Nordics for a clear cultural reason. The Nordics have a long oral tobacco tradition and the US has a mature smokeless market. Consumers there are not unfamiliar with placing a pouch under the lip, so brand education costs less.
Outside those regions, the oral habit does not replicate automatically. Reuters cited Jefferies analysts describing the absence of an oral nicotine culture as one of the biggest obstacles to cross-regional expansion.
One counterweight deserves equal attention: BAT’s pouch volumes across Asia, the Middle East and Africa grew 27.5% year on year in the first half of 2026, to roughly 700 million pouches. That is still well short of the combined 3 billion-plus in the US and Europe, but it shows demand is not permanently locked to the Nordics and North America.
The Regulatory Free Ride Is Ending — and Compliance Becomes the Moat
After frantic growth, regulation arrives. The WHO’s first global report dedicated to nicotine pouches, published in May 2026, found roughly 160 countries with no specific rules, 16 countries banning sale, and 32 countries applying regulation of some form. The phase of growing wild in a regulatory vacuum is closing fast, and because the rules are highly fragmented, companies will face higher costs for market access, packaging, testing and continuing compliance.
| Regulatory path | What it constrains | Packaging consequence |
|---|---|---|
| Outright prohibition | Sale of the category | Market excluded; no packaging route |
| Plain packaging rules | Brand decoration and colour | Differentiation shifts to structure and finish |
| Age and advertising control | Who may buy, how it is promoted | Warning area, labelling versions per market |
| Product-by-product authorisation | Each SKU individually | Dose consistency, traceability, documentation |
It also proves something: under a strict review system, a compliant nicotine pouch can still obtain differentiated risk information. For leading companies with the capital, data, R&D and quality management to clear the bar, regulation is not only a cost. It gradually becomes a moat that clears out low-quality players. The tension between the FDA’s opening and the WHO’s caution is examined in our piece on the growth bet.
What Is Actually Scarce: End-to-End Compliant Delivery
As the category expands quickly while flavour, nicotine strength and advertising space are progressively tightened, the value of packaging does not fall. It gets redefined. Child resistance, seal and freshness, used-pouch storage, warning information, batch traceability, material safety, automated filling compatibility and cross-market version management — each of these pushes the pack from “a surface that carries the look” toward compliance infrastructure.
For brand owners preparing to enter the US, Europe, the Nordics, the Middle East or Southeast Asia, the effective path is not to settle the appearance first and bolt on structure and testing later. It is to lock target market, pouch specification, fill count, opening logic, line tact time and compliance documentation at the design stage — which is what avoids re-cut tools, line changes, relabelling and written-off inventory downstream.
So is the nicotine pouch the next trillion-scale growth curve? If “ending cigarettes” means one category clearing cigarettes out of the market within a few years, then no. But if it means the combustible cigarette’s monopoly on global nicotine profit being dismantled piece by piece, that migration has already begun — and the pouch is standing in one of the best positions on the board.
